Nevro Share Holder Equity 2013-2022 | NVRO

Nevro share holder equity from 2013 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
Nevro Annual Share Holder Equity
(Millions of US $)
2022 $324
2021 $304
2020 $388
2019 $216
2018 $245
2017 $249
2016 $249
2015 $235
2014 $172
2013 $67
2012 $44
Nevro Quarterly Share Holder Equity
(Millions of US $)
2022-12-31 $324
2022-09-30 $325
2022-06-30 $230
2022-03-31 $240
2021-12-31 $304
2021-09-30 $319
2021-06-30 $358
2021-03-31 $366
2020-12-31 $388
2020-09-30 $380
2020-06-30 $374
2020-03-31 $215
2019-12-31 $216
2019-09-30 $198
2019-06-30 $202
2019-03-31 $214
2018-12-31 $245
2018-09-30 $244
2018-06-30 $246
2018-03-31 $243
2017-12-31 $249
2017-09-30 $244
2017-06-30 $241
2017-03-31 $243
2016-12-31 $249
2016-09-30 $248
2016-06-30 $246
2016-03-31 $229
2015-12-31 $235
2015-09-30 $244
2015-06-30 $262
2015-03-31 $159
2014-12-31 $172
2014-09-30 $47
2014-06-30 $0
2014-03-31 $0
2013-12-31
2013-09-30 $0
2012-12-31 $44
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.175B $0.406B
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.492B 24.17
Edwards Lifesciences (EW) United States $49.046B 32.63
Alcon (ALC) Switzerland $33.478B 30.63
STERIS (STE) Ireland $18.499B 23.44
Fresenius Medical Care AG KGaA (FMS) Germany $12.188B 12.74
Teleflex (TFX) United States $11.596B 18.91
Penumbra (PEN) United States $10.582B 1630.35
Globus Medical (GMED) United States $5.353B 25.78
Integer Holdings (ITGR) United States $2.578B 19.99
Glaukos (GKOS) United States $2.434B 0.00
Paragon 28 (FNA) United States $1.402B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.348B 17.53
Artivion (AORT) United States $0.496B 244.80